New partnership with CATALIS QUÉBEC
The partners and stakeholders involved in clinical research in Quebec are coming together as part of a large-scale collective project to ensure Quebec is recognized as a global hub for clinical trials
Kidney Cancer Canada joins more than 30 patient organizations and patient partners who represent the patient’s voice within the Network and contribute to CATALIS’ mission of optimizing clinical research in Quebec.
CATALIS coordinated the development of the Clinical Trials Quebec website which offers impartial, comprehensive, and accessible information on clinical research, as well as tools and services to improve Quebecers’ access to trials.
“Over the past eight years, treatment options for kidney cancer have increased and survival rates for kidney cancer patients have improved – thanks to clinical trials. At Kidney Cancer Canada, we encourage patients to ask about clinical trials and want to provide them with the tools to facilitate that conversation with their oncologist. We are excited to partner with CATALIS, whose mission is to optimise the clinical research environment by accelerating, facilitating, and increasing the number of clinical trials in Quebec. They have developed a patient-centric tool that allows patients to search for trials and helps them along the way. We are strong advocates of shared decision-making, and our partnership with CATALIS is another step in helping our Quebec community start conversations with their doctors about their treatment options.” – Kidney Cancer Canada
